EcoR1 Capital LLC 13D and 13G filings for LENZ Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-08 2:46 pm Purchase |
2024-03-21 | 13G | LENZ Therapeutics, Inc. LENZ |
EcoR1 Capital LLC | 1,219,774 4.800% |
1,219,774 (New Position) |
Filing |